| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/07/2013 | US20130059868 Treatment of gout |
| 03/07/2013 | US20130059867 Salt of fused heterocyclic derivative and crystal thereof |
| 03/07/2013 | US20130059866 Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma |
| 03/07/2013 | US20130059865 Compounds having antiviral properties |
| 03/07/2013 | US20130059864 Inhibiting neurotransmitter reuptake |
| 03/07/2013 | US20130059863 Substituted n-heteroaryl spirolactam bipyrrolidines, preparation and therapeutic use thereof |
| 03/07/2013 | US20130059862 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof |
| 03/07/2013 | US20130059861 Method for inducing tumor apoptosis by increasing nitric oxide levels |
| 03/07/2013 | US20130059860 Naphthalene carboxamide m1 receptor positive allosteric modulators |
| 03/07/2013 | US20130059859 Predictive biomarkers for pi3k/akt kinase pathway inhibitor efficacy |
| 03/07/2013 | US20130059858 Benzofuranyl analogues as gpr119 modulators |
| 03/07/2013 | US20130059857 Methods and compositions for safe and effective treatment of telangiectasia |
| 03/07/2013 | US20130059856 Agonists of gpr131 and uses thereof |
| 03/07/2013 | US20130059855 Crystal of di(arylamino)aryl compound |
| 03/07/2013 | US20130059854 Dosage Form for Insertion Into the Mouth |
| 03/07/2013 | US20130059853 Biaryl phosphodiesterase inhibitors |
| 03/07/2013 | US20130059852 Compounds for treating disease, for administering, and for pharmaceutical compositions |
| 03/07/2013 | US20130059851 Methods of Diagnosing and Treating Cancer in Patients Having or Developing Resistance to a First Cancer Therapy |
| 03/07/2013 | US20130059850 Aza-indole derivatives useful as modulators of faah |
| 03/07/2013 | US20130059849 Azaindazoles |
| 03/07/2013 | US20130059848 Cannabinoid-2 agonists |
| 03/07/2013 | US20130059847 Substituted n-(3-(pyrimidin-4-yl)phenyl)acrylamide analogs as tyrosine receptor kinase btk inhibitors |
| 03/07/2013 | US20130059846 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | US20130059845 Bicyclic agonists of gpr131 and uses thereof |
| 03/07/2013 | US20130059844 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 03/07/2013 | US20130059843 Thiazolyl- and Oxazolyl-Isoquinolinones and Methods for Using Them |
| 03/07/2013 | US20130059842 Manufacturing of quick release pharmaceutical compositons of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention |
| 03/07/2013 | US20130059841 Therapeutic compositions and methods |
| 03/07/2013 | US20130059840 Sulfonamido pyrrolidine compounds which inhibit beta-secretase activity and methods of use thereof |
| 03/07/2013 | US20130059839 Pyridylthiazole-based ureas as inhibitors of rho associated protein kinase (rock) and methods of use |
| 03/07/2013 | US20130059838 Substituted n-heteroaryl tetrahydro-isoquinoline derivatives, preparation and therapeutic use thereof |
| 03/07/2013 | US20130059837 Benzazepine compound |
| 03/07/2013 | US20130059836 Pyrazolopyrimidine compounds for the treatment of cancer |
| 03/07/2013 | US20130059835 Heterocyclylamines as pi3k inhibitors |
| 03/07/2013 | US20130059834 Pyrrolopyrazine kinase inhibitors |
| 03/07/2013 | US20130059833 Pde10 modulators |
| 03/07/2013 | US20130059832 Compounds and compositions as c-kit kinase inhibitors |
| 03/07/2013 | US20130059831 Novel crystal form of pyrrolidylthiocarbapenem derivative |
| 03/07/2013 | US20130059830 Novel prolylcarboxypeptidase inhibitors |
| 03/07/2013 | US20130059829 Treatment of central nervous system disorders |
| 03/07/2013 | US20130059828 Pharmaceutical composition |
| 03/07/2013 | US20130059827 Intranasal 0.6% and 0.72% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
| 03/07/2013 | US20130059826 Inhalant Formulation Containing Sulfoalkyl Ether Cyclodextrin and Corticosteroid |
| 03/07/2013 | US20130059825 Antibodies to 25-HYDROXY Vitamin D2 and D3 and Uses Thereof |
| 03/07/2013 | US20130059824 Methods for treating mild cognitive impairment |
| 03/07/2013 | US20130059823 Diazeniumdiolate Cyclohexyl Derivatives |
| 03/07/2013 | US20130059822 Arylfluorophosphate Inhibitors of Intestinal Apical Membrane Sodium/Phosphate Co-Transport |
| 03/07/2013 | US20130059821 Bicyclic aryl sphingosine 1-phosphate analogs |
| 03/07/2013 | US20130059820 Inositol pyrophosphates, and methods of use thereof |
| 03/07/2013 | US20130059819 Inhibitors of fatty acid amide hydrolase |
| 03/07/2013 | US20130059818 Carbosilane dendrimers and the use thereof as antiviral agents |
| 03/07/2013 | US20130059817 Composition for reducing absorption of dietary fat |
| 03/07/2013 | US20130059816 Compositions and methods for treatment of autoimmune and other disease |
| 03/07/2013 | US20130059815 Nutritional compositions containing human milk oligosaccharides and methods for using the same |
| 03/07/2013 | US20130059814 Anti-inflammatory dermatological composition comprising corticosteroids and hyaluronate fragments, and uses thereof |
| 03/07/2013 | US20130059813 Treatment of dermatological conditions |
| 03/07/2013 | US20130059812 Composition for treating chronic hepatitis b, containing clevudine and adefovir dipivoxil |
| 03/07/2013 | US20130059811 Method for treating and preventing arthritis |
| 03/07/2013 | US20130059810 Pharmaceutical compositions comprising forms of 5-azacytidine |
| 03/07/2013 | US20130059809 Pharmaceutical compositions comprising forms of 5-azacytidine |
| 03/07/2013 | US20130059808 Aminoglycoside derivatives |
| 03/07/2013 | US20130059807 Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions |
| 03/07/2013 | US20130059806 Epigenetic co-repressors of the gamma-globin gene and methods of using same |
| 03/07/2013 | US20130059805 Composition comprising an amorphous non-crystalline glass form of azithromycin |
| 03/07/2013 | US20130059804 Synthesis of compounds useful as modulators of amyloid-beta production |
| 03/07/2013 | US20130059803 Boron-containing small molecules |
| 03/07/2013 | US20130059802 Boron-containing small molecules |
| 03/07/2013 | US20130059801 Fatty acid amides, compositions and methods of use |
| 03/07/2013 | US20130059795 Novel Composition Of Matter For Delivering Lipid-Soluble Materials, And A Method For Producing It |
| 03/07/2013 | US20130059792 Traceability of Cellular Cycle Ano |
| 03/07/2013 | US20130059787 Methods of using human protein kinase c delta viii as a biomarker |
| 03/07/2013 | US20130059786 Compositions and methods for the treatment of cardiac and vascular disease |
| 03/07/2013 | US20130059777 Modulation of glucose-6-phosphatase translocase expression |
| 03/07/2013 | US20130059774 Efflux pump inhibitors |
| 03/07/2013 | US20130059769 Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications |
| 03/07/2013 | US20130059768 Lipid compositions with high dha content |
| 03/07/2013 | US20130059382 Biomedical materials for tissue engineering |
| 03/07/2013 | US20130059021 Perfluoro(n-butylcyclohexane) compositions and uses thereof |
| 03/07/2013 | US20130059019 Methods and compositions for treating inflammation of skin |
| 03/07/2013 | US20130059018 Phytocannabinoids in the treatment of cancer |
| 03/07/2013 | US20130059015 Human Cancer micro-RNA Expression Profiles Predictive of Chemo-Response |
| 03/07/2013 | US20130059010 Alcohol-resistant oral pharmaceutical form |
| 03/07/2013 | US20130059007 Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes |
| 03/07/2013 | US20130059005 Bupropion hydrobromide polymorphs |
| 03/07/2013 | US20130059004 Oral drug delivery system |
| 03/07/2013 | US20130059003 Sustained release donepezil formulations |
| 03/07/2013 | US20130059002 Pharmaceutical compositions comprising a combination of metformin and sitagliptin |
| 03/07/2013 | US20130058998 Encapsulated n-acetylmannosamine or n-acetylneuraminic acid to increase sialylation |
| 03/07/2013 | US20130058996 LIPOSOME CONTAINING shRNA MOLECULE TARGETING A THYMIDYLATE SYNTHASE AND USE THEREOF |
| 03/07/2013 | US20130058992 Gene expression signatures associated with response to imatinib mesylate in gastrointestinal stromal tumors and use thereof for predicting patient response to therapy and identification of agents which have efficacy for the treatment of cancer |
| 03/07/2013 | US20130058987 Enhanced folic acid fluorescent material, multifluorescent porous compositions of matter and potential applications thereof |
| 03/07/2013 | US20130058985 Spray-Pumpable Composition Suitable for Topical Skin Application |
| 03/07/2013 | US20130058984 Single-walled carbon nanotube/bioactive substance complexes and methods related thereto |
| 03/07/2013 | US20130058983 Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses |
| 03/07/2013 | US20130058980 Small molecule inhibitors of protein kinases |
| 03/07/2013 | US20130058957 Dendritic cell immunoreceptor agonist |
| 03/07/2013 | US20130058954 Diagnostic and therapeutic methods for corneal ectasia following refractive surgery, keratoconus or pellucid degeneration |
| 03/07/2013 | US20130058949 Antagonists of il-6 to prevent or treat thrombosis |
| 03/07/2013 | US20130058940 Novel Gene And Protein Associated With Angiogenesis And Endothelial Cell Specific Apoptosis |
| 03/07/2013 | US20130058938 Gna11 mutations in melanoma |